The European Consortium "Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases" (AVITHRAPID) aims to support the search for novel broad-spectrum antiviral compounds by advancing multiple approaches. Building on a pre-existing set of bioactive small molecules, which are at…

 The aim of this translational research project is to conduct a first in human (clinical phase I) study and test BAP5191, a new formulation intended to be a cure for cutaneous leishmaniasis – a neglected stigmatizing and debilitating tropical disease with an estimated 600 000 to 1 million of new…